Clostridium Difficile Diagnostics and Treatment Market 2019-2025
08-Jan-2019 | Number of pages: 194 | Report Id: BMRC HC 112 | Report Format: | Status: Published

Clostridium Difficile Diagnostics and Treatment Market By Product Type (Metronidazole, Vancomycin, Fidaxomicin, Bezlotoxumab), By Test Type (Enzyme Immunoassays, Real-Time Polymerase Chain Reaction, Nucleic Amplification Tests), By Distribution Channel (Hospitals & Clinics, Diagnostic Laboratories, Pharmacies), Industry Analysis, Trends, and Forecast 2019 – 2025

Clostridium Difficile Diagnostics and Treatment Market is valued around USD 1362.99 Million in 2018 and expected to reach USD 2320.83 Million by 2025 with the CAGR of 7.9% over the forecast period. Increased prevalence of clostridium difficile infection and increase in research and development is the key drivers for Global Clostridium Difficile Diagnostics and Treatment Market.

Clostridium Difficile Diagnostics and Treatment market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about clostridium difficile diagnostics and treatment market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with product type, test type, and distribution channel.

Clostridium difficile is caused by clostridium difficile bacteria and it is the most common infection among older adults. More than 80% of C. difficile deaths occur in people older than 65 or more. Clostridium difficile colitis results from disruption of normal, healthy bacteria in the colon, often as a result of antibiotics. Clostridium difficile is caused by clostridium difficile bacteria which is common infection among older adults. Growing prevalence of healthcare-associated infections has been one of the major drivers of the global clostridium difficile diagnostics and treatment market. In 2011 C. difficile was estimated to cause about half a million infections among adults in United States due to which ~29,000 people died within 30 days of the initial diagnosis. During the study of Global Clostridium Difficile Diagnostics and Treatment market, we have considered clostridium difficile diagnostics and treatment product type and test type to analyze the market.

Clostridium Difficile Diagnostics and Treatment Market Analysis

There are various factors driving the growth of the clostridium difficile diagnostics and treatment market, one of the major driving the growth of the market are increased prevalence of clostridium difficile infection over the period of time. Moreover, robust product pipeline of different therapies for the treatment of clostridium difficile infection are expected to support the growth of clostridium difficile diagnostics and treatment market. However, lack of awareness among people are expected inhibit the growth of clostridium difficile diagnostics and treatment market over the forecast period.

Clostridium Difficile Diagnostics and Treatment Market Share

Clostridium Difficile Diagnostics and Treatment Market Revenue (USD Million) Analysis by Regional and Global, 2019-2025

Global clostridium difficile diagnostics and treatment market report covers prominent players like Thermo Fisher Scientific Inc., Actelion Pharmaceuticals, Baxter International Inc., Alere, Inc., Pfizer, Inc., Novartis AG, Trinity Biotech, Summit Therapeutics, Sanofi S.A., AstraZeneca Plc., Merck & Co., and others.

Clostridium Difficile Diagnostics and Treatment Market Segmentation –

By Product Type 

  • Metronidazole
  • Vancomycin
  • Fidaxomicin
  • Bezlotoxumab
  • Others

By Test Type 

  • Enzyme Immunoassays
  • Real-Time Polymerase Chain Reaction (RT-PCR)
  • Nucleic Amplification Tests (NAAT)
  • Others

By Distribution Channel 

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Pharmacies

By Region

  • North America
    • S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Clostridium Difficile Diagnostics and Treatment Market key Players

Merck & Co.
Thermo Fisher Scientific Inc.
Actelion Pharmaceuticals
Baxter International Inc.
Alere, Inc.
Pfizer, Inc.
Novartis AG
Trinity Biotech
Summit Therapeutics

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Clostridium Difficile Diagnostics and Treatment Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Clostridium Difficile Diagnostics and Treatment Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Antibacterial Drugs Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Clostridium Difficile Diagnostics and Treatment Market Overview: Quantitative Analysis
    • Global Antibacterial Drugs Market Consumption, Market Share ( %) and Growth Rate, 2015-2025
    • Global Antibacterial Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2015-2025
  2. Chapter – Global Clostridium Difficile Diagnostics and Treatment Market Analysis: by Product Type
  3. Chapter – Global Clostridium Difficile Diagnostics and Treatment Market Analysis: by Test Type
  4. Chapter – Global Clostridium Difficile Diagnostics and Treatment Market Analysis: by Distribution Channel
  5. Chapter – Global Clostridium Difficile Diagnostics and Treatment Market Analysis: by Manufacturer
    • Global Antibacterial Drugs Market Revenue (USD Million), by Manufacturer, 2015-2018
    • Global Antibacterial Drugs Market Share (%), by Manufacturer, 2015-2018
    • Global Antibacterial Drugs Market Price (USD/Unit), by Manufacturer, 2015-2018
    • Global Antibacterial Drugs Market Revenue Growth Rate (%), by Manufacturer, 2015-2018
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  6. Chapter – Clostridium Difficile Diagnostics and Treatment Market: Regional Analysis
    • North America
      • North America Clostridium Difficile Diagnostics and Treatment Market Revenue (USD Million) and Growth Rate (%), 2015-2025.
      • North America Clostridium Difficile Diagnostics and Treatment Market Revenue (USD Million) By Country, 2015-2025.
      • North America Antibacterial Drugs Revenue Market Share (%) By Country, 2015-2025.
      • North America Clostridium Difficile Diagnostics and Treatment Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015-2025.
      • North America Clostridium Difficile Diagnostics and Treatment Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015-2025.
      • North America Clostridium Difficile Diagnostics and Treatment Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015-2025.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  7. Chapter – Company Profiles
    • Merck & Co.
      • Overview
      • Financials
      • Product portfolio
      • Clostridium Difficile Diagnostics and Treatment Market Revenue (USD Million), Consumption and Market Share (%), 2014 – 2018
      • Clostridium Difficile Diagnostics and Treatment Sales Market Share (%), 2014 – 2017
      • Business strategy
      • Recent developments
    • Thermo Fisher Scientific Inc.
    • Actelion Pharmaceuticals
    • Baxter International Inc.
    • Alere, Inc.
    • Pfizer, Inc.
    • Novartis AG
    • Trinity Biotech
    • Summit Therapeutics
    • Sanofi S.A.
    • AstraZeneca Plc.
    • Others
  8. Chapter – Market Research and Findings

Merck & Co.
Thermo Fisher Scientific Inc.
Actelion Pharmaceuticals
Baxter International Inc.
Alere, Inc.
Pfizer, Inc.
Novartis AG
Trinity Biotech
Summit Therapeutics
Sanofi S.A.
AstraZeneca Plc.
Others